Bruker Corporation (NASDAQ: BRKR) Stock Competitors & Peer Comparison
See BRKR's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for BRKR and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BRKR | $59.27 | +3.95% | 9B | 29.78 | $1.99 | +0.35% |
| ABT | $110.91 | +1.08% | 191.9B | 21.29 | $5.21 | +2.24% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| SYK | $347.21 | -0.27% | 133.1B | 25.93 | $13.39 | +1.00% |
| MDT | $90.76 | +0.09% | 116.2B | 16.41 | $5.53 | +3.14% |
| BSX | $51.42 | +0.45% | 76.4B | 16.58 | $3.10 | N/A |
| EW | $93.05 | -0.65% | 53.6B | 34.46 | $2.70 | N/A |
| DXCM | $90.80 | +1.42% | 34.3B | 38.97 | $2.33 | N/A |
| RMD | $226.00 | +0.52% | 32.8B | 20.99 | $10.77 | +1.06% |
| PHG | $26.80 | -0.92% | 26.2B | 15.32 | $1.75 | +3.69% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
BRKR vs ABT Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, ABT has a market cap of 191.9B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while ABT trades at $110.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas ABT's P/E ratio is 21.29. In terms of profitability, BRKR's ROE is -0.03%, compared to ABT's ROE of +0.11%. Regarding short-term risk, BRKR is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
BRKR vs BSX-PA Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, BRKR's ROE is -0.03%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, BRKR is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check BSX-PA's competition here
Stryker Corporation (NYSE: SYK)
BRKR vs SYK Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, SYK has a market cap of 133.1B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while SYK trades at $347.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas SYK's P/E ratio is 25.93. In terms of profitability, BRKR's ROE is -0.03%, compared to SYK's ROE of +0.16%. Regarding short-term risk, BRKR is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check SYK's competition here
Medtronic plc (NYSE: MDT)
BRKR vs MDT Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, MDT has a market cap of 116.2B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while MDT trades at $90.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas MDT's P/E ratio is 16.41. In terms of profitability, BRKR's ROE is -0.03%, compared to MDT's ROE of +0.10%. Regarding short-term risk, BRKR is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check MDT's competition here
Boston Scientific Corporation (NYSE: BSX)
BRKR vs BSX Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, BSX has a market cap of 76.4B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while BSX trades at $51.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas BSX's P/E ratio is 16.58. In terms of profitability, BRKR's ROE is -0.03%, compared to BSX's ROE of +0.15%. Regarding short-term risk, BRKR is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
BRKR vs EW Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, EW has a market cap of 53.6B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while EW trades at $93.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas EW's P/E ratio is 34.46. In terms of profitability, BRKR's ROE is -0.03%, compared to EW's ROE of +0.10%. Regarding short-term risk, BRKR is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
BRKR vs DXCM Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, DXCM has a market cap of 34.3B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while DXCM trades at $90.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas DXCM's P/E ratio is 38.97. In terms of profitability, BRKR's ROE is -0.03%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, BRKR is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check DXCM's competition here
ResMed Inc. (NYSE: RMD)
BRKR vs RMD Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, RMD has a market cap of 32.8B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while RMD trades at $226.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas RMD's P/E ratio is 20.99. In terms of profitability, BRKR's ROE is -0.03%, compared to RMD's ROE of +0.24%. Regarding short-term risk, BRKR is more volatile compared to RMD. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check RMD's competition here
Koninklijke Philips N.V. (NYSE: PHG)
BRKR vs PHG Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, PHG has a market cap of 26.2B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while PHG trades at $26.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas PHG's P/E ratio is 15.32. In terms of profitability, BRKR's ROE is -0.03%, compared to PHG's ROE of +0.10%. Regarding short-term risk, BRKR is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
BRKR vs ZBH Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, ZBH has a market cap of 18.9B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while ZBH trades at $97.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas ZBH's P/E ratio is 11.54. In terms of profitability, BRKR's ROE is -0.03%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, BRKR is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
BRKR vs ABMD Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas ABMD's P/E ratio is 65.36. In terms of profitability, BRKR's ROE is -0.03%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, BRKR is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check ABMD's competition here
Penumbra, Inc. (NYSE: PEN)
BRKR vs PEN Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, PEN has a market cap of 12.9B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while PEN trades at $326.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas PEN's P/E ratio is 85.30. In terms of profitability, BRKR's ROE is -0.03%, compared to PEN's ROE of +0.11%. Regarding short-term risk, BRKR is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check PEN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
BRKR vs SWAV Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas SWAV's P/E ratio is 78.76. In terms of profitability, BRKR's ROE is -0.03%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, BRKR is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check SWAV's competition here
Smith & Nephew plc (NYSE: SNN)
BRKR vs SNN Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, SNN has a market cap of 12.5B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while SNN trades at $29.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas SNN's P/E ratio is 14.05. In terms of profitability, BRKR's ROE is -0.03%, compared to SNN's ROE of +0.12%. Regarding short-term risk, BRKR is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check SNN's competition here
Align Technology, Inc. (NASDAQ: ALGN)
BRKR vs ALGN Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, ALGN has a market cap of 12.5B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while ALGN trades at $174.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas ALGN's P/E ratio is 15.86. In terms of profitability, BRKR's ROE is -0.03%, compared to ALGN's ROE of +0.14%. Regarding short-term risk, BRKR is more volatile compared to ALGN. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check ALGN's competition here
Globus Medical, Inc. (NYSE: GMED)
BRKR vs GMED Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, GMED has a market cap of 11.6B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while GMED trades at $85.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas GMED's P/E ratio is 19.30. In terms of profitability, BRKR's ROE is -0.03%, compared to GMED's ROE of +0.12%. Regarding short-term risk, BRKR is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check GMED's competition here
Glaukos Corporation (NYSE: GKOS)
BRKR vs GKOS Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, GKOS has a market cap of 11B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while GKOS trades at $186.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas GKOS's P/E ratio is -216.86. In terms of profitability, BRKR's ROE is -0.03%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, BRKR is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check GKOS's competition here
Insulet Corp. (NASDAQ: PODD)
BRKR vs PODD Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, PODD has a market cap of 10B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while PODD trades at $145.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas PODD's P/E ratio is 24.71. In terms of profitability, BRKR's ROE is -0.03%, compared to PODD's ROE of +0.27%. Regarding short-term risk, BRKR is less volatile compared to PODD. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check PODD's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
BRKR vs BIO Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, BIO has a market cap of 9.8B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while BIO trades at $362.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas BIO's P/E ratio is 39.04. In terms of profitability, BRKR's ROE is -0.03%, compared to BIO's ROE of +0.03%. Regarding short-term risk, BRKR is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check BIO's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
BRKR vs BIO-B Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, BIO-B has a market cap of 9.5B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while BIO-B trades at $348.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas BIO-B's P/E ratio is 103.33. In terms of profitability, BRKR's ROE is -0.03%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, BRKR is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check BIO-B's competition here
Masimo Corporation (NASDAQ: MASI)
BRKR vs MASI Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas MASI's P/E ratio is 44.43. In terms of profitability, BRKR's ROE is -0.03%, compared to MASI's ROE of +0.09%. Regarding short-term risk, BRKR is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check MASI's competition here
Inari Medical, Inc. (NASDAQ: NARI)
BRKR vs NARI Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas NARI's P/E ratio is -59.24. In terms of profitability, BRKR's ROE is -0.03%, compared to NARI's ROE of -0.00%. Regarding short-term risk, BRKR is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check NARI's competition here
LivaNova PLC (NASDAQ: LIVN)
BRKR vs LIVN Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, LIVN has a market cap of 4.4B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while LIVN trades at $80.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas LIVN's P/E ratio is 19.19. In terms of profitability, BRKR's ROE is -0.03%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, BRKR is less volatile compared to LIVN. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check LIVN's competition here
Integer Holdings Corporation (NYSE: ITGR)
BRKR vs ITGR Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, ITGR has a market cap of 4.2B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while ITGR trades at $125.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas ITGR's P/E ratio is 19.70. In terms of profitability, BRKR's ROE is -0.03%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, BRKR is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check ITGR's competition here
Haemonetics Corporation (NYSE: HAE)
BRKR vs HAE Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, HAE has a market cap of 4.2B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while HAE trades at $91.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas HAE's P/E ratio is 18.23. In terms of profitability, BRKR's ROE is -0.03%, compared to HAE's ROE of +0.11%. Regarding short-term risk, BRKR is less volatile compared to HAE. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check HAE's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
BRKR vs IRTC Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, IRTC has a market cap of 4.1B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while IRTC trades at $125.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas IRTC's P/E ratio is -195.86. In terms of profitability, BRKR's ROE is -0.03%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, BRKR is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check IRTC's competition here
Axonics, Inc. (NASDAQ: AXNX)
BRKR vs AXNX Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas AXNX's P/E ratio is -709.80. In terms of profitability, BRKR's ROE is -0.03%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, BRKR is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check AXNX's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
BRKR vs TMDX Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, TMDX has a market cap of 3B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while TMDX trades at $87.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas TMDX's P/E ratio is 44.17. In terms of profitability, BRKR's ROE is -0.03%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, BRKR is more volatile compared to TMDX. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check TMDX's competition here
AxoGen, Inc. (NASDAQ: AXGN)
BRKR vs AXGN Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, AXGN has a market cap of 2.7B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while AXGN trades at $49.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas AXGN's P/E ratio is 130.71. In terms of profitability, BRKR's ROE is -0.03%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, BRKR is more volatile compared to AXGN. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check AXGN's competition here
Butterfly Network, Inc. (NYSE: BFLY)
BRKR vs BFLY Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, BFLY has a market cap of 2.5B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while BFLY trades at $9.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas BFLY's P/E ratio is -39.35. In terms of profitability, BRKR's ROE is -0.03%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, BRKR is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check BFLY's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
BRKR vs UFPT Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, UFPT has a market cap of 2.5B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while UFPT trades at $322.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas UFPT's P/E ratio is 32.94. In terms of profitability, BRKR's ROE is -0.03%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, BRKR is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check UFPT's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
BRKR vs ESTA Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, ESTA has a market cap of 2.2B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while ESTA trades at $75.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas ESTA's P/E ratio is -59.98. In terms of profitability, BRKR's ROE is -0.03%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, BRKR is more volatile compared to ESTA. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check ESTA's competition here
NuVasive, Inc. (NASDAQ: NUVA)
BRKR vs NUVA Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas NUVA's P/E ratio is 75.00. In terms of profitability, BRKR's ROE is -0.03%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, BRKR is more volatile compared to NUVA. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check NUVA's competition here
Novocure Ltd (NASDAQ: NVCR)
BRKR vs NVCR Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, NVCR has a market cap of 2B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while NVCR trades at $17.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas NVCR's P/E ratio is -11.50. In terms of profitability, BRKR's ROE is -0.03%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, BRKR is more volatile compared to NVCR. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check NVCR's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
BRKR vs INSP Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, INSP has a market cap of 1.7B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while INSP trades at $58.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas INSP's P/E ratio is 25.67. In terms of profitability, BRKR's ROE is -0.03%, compared to INSP's ROE of +0.18%. Regarding short-term risk, BRKR is more volatile compared to INSP. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check INSP's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
BRKR vs TNDM Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, TNDM has a market cap of 1.6B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while TNDM trades at $23.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas TNDM's P/E ratio is -21.31. In terms of profitability, BRKR's ROE is -0.03%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, BRKR is more volatile compared to TNDM. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check TNDM's competition here
CONMED Corporation (NYSE: CNMD)
BRKR vs CNMD Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, CNMD has a market cap of 1.5B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while CNMD trades at $49.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas CNMD's P/E ratio is 10.89. In terms of profitability, BRKR's ROE is -0.03%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, BRKR is more volatile compared to CNMD. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check CNMD's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
BRKR vs ATEC Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, ATEC has a market cap of 1.5B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while ATEC trades at $9.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas ATEC's P/E ratio is -160.50. In terms of profitability, BRKR's ROE is -0.03%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, BRKR is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check ATEC's competition here
Enovis Corporation (NYSE: ENOV)
BRKR vs ENOV Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, ENOV has a market cap of 1.4B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while ENOV trades at $24.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas ENOV's P/E ratio is 7.07. In terms of profitability, BRKR's ROE is -0.03%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, BRKR is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check ENOV's competition here
Artivion, Inc. (NYSE: AORT)
BRKR vs AORT Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, AORT has a market cap of 1.4B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while AORT trades at $28.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas AORT's P/E ratio is 47.72. In terms of profitability, BRKR's ROE is -0.03%, compared to AORT's ROE of -0.01%. Regarding short-term risk, BRKR is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check AORT's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
BRKR vs IART Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, IART has a market cap of 1.4B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while IART trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas IART's P/E ratio is 7.36. In terms of profitability, BRKR's ROE is -0.03%, compared to IART's ROE of -0.01%. Regarding short-term risk, BRKR is more volatile compared to IART. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check IART's competition here
Heska Corporation (NASDAQ: HSKA)
BRKR vs HSKA Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas HSKA's P/E ratio is -62.49. In terms of profitability, BRKR's ROE is -0.03%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, BRKR is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check HSKA's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
BRKR vs PRCT Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, PRCT has a market cap of 1.2B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while PRCT trades at $21.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas PRCT's P/E ratio is -10.95. In terms of profitability, BRKR's ROE is -0.03%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, BRKR is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check PRCT's competition here
Avanos Medical, Inc. (NYSE: AVNS)
BRKR vs AVNS Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas AVNS's P/E ratio is 27.77. In terms of profitability, BRKR's ROE is -0.03%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, BRKR is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check AVNS's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
BRKR vs LMRI Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, LMRI has a market cap of 1.1B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while LMRI trades at $11.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas LMRI's P/E ratio is -22.82. In terms of profitability, BRKR's ROE is -0.03%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, BRKR is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check LMRI's competition here
IRadimed Corporation (NASDAQ: IRMD)
BRKR vs IRMD Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while IRMD trades at $87.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas IRMD's P/E ratio is 43.92. In terms of profitability, BRKR's ROE is -0.03%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, BRKR is less volatile compared to IRMD. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check IRMD's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
BRKR vs SILK Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas SILK's P/E ratio is -18.96. In terms of profitability, BRKR's ROE is -0.03%, compared to SILK's ROE of -0.35%. Regarding short-term risk, BRKR is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check SILK's competition here
Paragon 28, Inc. (NYSE: FNA)
BRKR vs FNA Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas FNA's P/E ratio is -19.83. In terms of profitability, BRKR's ROE is -0.03%, compared to FNA's ROE of -0.35%. Regarding short-term risk, BRKR is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check FNA's competition here
Bioventus Inc. (NASDAQ: BVS)
BRKR vs BVS Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, BVS has a market cap of 942.7M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while BVS trades at $13.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas BVS's P/E ratio is 18.31. In terms of profitability, BRKR's ROE is -0.03%, compared to BVS's ROE of +0.28%. Regarding short-term risk, BRKR is more volatile compared to BVS. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check BVS's competition here
InMode Ltd. (NASDAQ: INMD)
BRKR vs INMD Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, INMD has a market cap of 875.4M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while INMD trades at $15.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas INMD's P/E ratio is 10.58. In terms of profitability, BRKR's ROE is -0.03%, compared to INMD's ROE of +0.12%. Regarding short-term risk, BRKR is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check INMD's competition here
CeriBell, Inc. (NASDAQ: CBLL)
BRKR vs CBLL Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, CBLL has a market cap of 869.3M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while CBLL trades at $22.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas CBLL's P/E ratio is -14.06. In terms of profitability, BRKR's ROE is -0.03%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, BRKR is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check CBLL's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
BRKR vs AVR Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, AVR has a market cap of 862.4M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while AVR trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas AVR's P/E ratio is -3.98. In terms of profitability, BRKR's ROE is -0.03%, compared to AVR's ROE of -0.78%. Regarding short-term risk, BRKR is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check AVR's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
BRKR vs CSII Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, CSII has a market cap of 844M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas CSII's P/E ratio is -20.83. In terms of profitability, BRKR's ROE is -0.03%, compared to CSII's ROE of -0.14%. Regarding short-term risk, BRKR is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check CSII's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
BRKR vs SIBN Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, SIBN has a market cap of 842.6M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while SIBN trades at $19.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas SIBN's P/E ratio is -55.88. In terms of profitability, BRKR's ROE is -0.03%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, BRKR is more volatile compared to SIBN. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check SIBN's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
BRKR vs AHCO Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, AHCO has a market cap of 785M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while AHCO trades at $5.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas AHCO's P/E ratio is 11.78. In terms of profitability, BRKR's ROE is -0.03%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, BRKR is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check AHCO's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
BRKR vs BBNX Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, BBNX has a market cap of 779.7M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while BBNX trades at $17.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas BBNX's P/E ratio is -11.48. In terms of profitability, BRKR's ROE is -0.03%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, BRKR is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check BBNX's competition here
Varex Imaging Corporation (NASDAQ: VREX)
BRKR vs VREX Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, VREX has a market cap of 776.7M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while VREX trades at $18.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas VREX's P/E ratio is 19.42. In terms of profitability, BRKR's ROE is -0.03%, compared to VREX's ROE of +0.05%. Regarding short-term risk, BRKR is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check VREX's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
BRKR vs SSII Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, SSII has a market cap of 738.5M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while SSII trades at $3.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas SSII's P/E ratio is -71.97. In terms of profitability, BRKR's ROE is -0.03%, compared to SSII's ROE of -0.23%. Regarding short-term risk, BRKR is more volatile compared to SSII. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check SSII's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
BRKR vs BWAY Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, BWAY has a market cap of 651.1M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while BWAY trades at $16.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas BWAY's P/E ratio is 42.17. In terms of profitability, BRKR's ROE is -0.03%, compared to BWAY's ROE of +0.12%. Regarding short-term risk, BRKR is less volatile compared to BWAY. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check BWAY's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
BRKR vs KIDS Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, KIDS has a market cap of 638.5M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while KIDS trades at $24.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas KIDS's P/E ratio is -21.07. In terms of profitability, BRKR's ROE is -0.03%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, BRKR is more volatile compared to KIDS. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check KIDS's competition here
Surmodics, Inc. (NASDAQ: SRDX)
BRKR vs SRDX Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas SRDX's P/E ratio is -34.66. In terms of profitability, BRKR's ROE is -0.03%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, BRKR is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check SRDX's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
BRKR vs CTKB Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, CTKB has a market cap of 612.1M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while CTKB trades at $4.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas CTKB's P/E ratio is -25.11. In terms of profitability, BRKR's ROE is -0.03%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, BRKR is more volatile compared to CTKB. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check CTKB's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
BRKR vs DCTH Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, DCTH has a market cap of 590.7M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while DCTH trades at $17.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas DCTH's P/E ratio is 1711.00. In terms of profitability, BRKR's ROE is -0.03%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, BRKR is more volatile compared to DCTH. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check DCTH's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
BRKR vs APEN Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas APEN's P/E ratio is -9.43. In terms of profitability, BRKR's ROE is -0.03%, compared to APEN's ROE of -0.85%. Regarding short-term risk, BRKR is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check APEN's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
BRKR vs TCMD Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, TCMD has a market cap of 552.9M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while TCMD trades at $24.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas TCMD's P/E ratio is 27.85. In terms of profitability, BRKR's ROE is -0.03%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, BRKR is less volatile compared to TCMD. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check TCMD's competition here
Cerus Corporation (NASDAQ: CERS)
BRKR vs CERS Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, CERS has a market cap of 546.1M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while CERS trades at $2.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas CERS's P/E ratio is -54.09. In terms of profitability, BRKR's ROE is -0.03%, compared to CERS's ROE of -0.10%. Regarding short-term risk, BRKR is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check CERS's competition here
ZimVie Inc. (NASDAQ: ZIMV)
BRKR vs ZIMV Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, BRKR's ROE is -0.03%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, BRKR is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check ZIMV's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
BRKR vs NPCE Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, NPCE has a market cap of 496.4M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while NPCE trades at $14.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas NPCE's P/E ratio is -22.40. In terms of profitability, BRKR's ROE is -0.03%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, BRKR is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check NPCE's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
BRKR vs SGHT Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, SGHT has a market cap of 450.5M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while SGHT trades at $8.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas SGHT's P/E ratio is -14.79. In terms of profitability, BRKR's ROE is -0.03%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, BRKR is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check SGHT's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
BRKR vs CLPT Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, CLPT has a market cap of 446.8M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while CLPT trades at $15.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas CLPT's P/E ratio is -12.63. In terms of profitability, BRKR's ROE is -0.03%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, BRKR is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check CLPT's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
BRKR vs OFIX Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, OFIX has a market cap of 420.4M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while OFIX trades at $10.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas OFIX's P/E ratio is -13.59. In terms of profitability, BRKR's ROE is -0.03%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, BRKR is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check OFIX's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
BRKR vs CATX Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, CATX has a market cap of 373.5M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while CATX trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas CATX's P/E ratio is -2.32. In terms of profitability, BRKR's ROE is -0.03%, compared to CATX's ROE of -0.42%. Regarding short-term risk, BRKR is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check CATX's competition here
Carlsmed, Inc. (NASDAQ: CARL)
BRKR vs CARL Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, CARL has a market cap of 373M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while CARL trades at $13.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas CARL's P/E ratio is -9.59. In terms of profitability, BRKR's ROE is -0.03%, compared to CARL's ROE of -0.38%. Regarding short-term risk, BRKR is less volatile compared to CARL. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check CARL's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
BRKR vs TLSI Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, TLSI has a market cap of 351.6M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while TLSI trades at $5.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas TLSI's P/E ratio is -3.40. In terms of profitability, BRKR's ROE is -0.03%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, BRKR is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check TLSI's competition here
Electromed, Inc. (AMEX: ELMD)
BRKR vs ELMD Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, ELMD has a market cap of 351.5M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while ELMD trades at $42.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas ELMD's P/E ratio is 36.28. In terms of profitability, BRKR's ROE is -0.03%, compared to ELMD's ROE of +0.22%. Regarding short-term risk, BRKR is more volatile compared to ELMD. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check ELMD's competition here
Picard Medical, Inc. (AMEX: PMI)
BRKR vs PMI Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, PMI has a market cap of 349.2M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while PMI trades at $3.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas PMI's P/E ratio is -2.83. In terms of profitability, BRKR's ROE is -0.03%, compared to PMI's ROE of +4.99%. Regarding short-term risk, BRKR is less volatile compared to PMI. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check PMI's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
BRKR vs PACB Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, PACB has a market cap of 344.8M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while PACB trades at $1.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas PACB's P/E ratio is -2.71. In terms of profitability, BRKR's ROE is -0.03%, compared to PACB's ROE of -49.62%. Regarding short-term risk, BRKR is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check PACB's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
BRKR vs SENS Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, SENS has a market cap of 331.4M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while SENS trades at $7.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas SENS's P/E ratio is -3.96. In terms of profitability, BRKR's ROE is -0.03%, compared to SENS's ROE of -1.66%. Regarding short-term risk, BRKR is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check SENS's competition here
CapsoVision, Inc. (NASDAQ: CV)
BRKR vs CV Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, CV has a market cap of 329.8M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while CV trades at $6.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas CV's P/E ratio is -2.64. In terms of profitability, BRKR's ROE is -0.03%, compared to CV's ROE of +1.27%. Regarding short-term risk, BRKR is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check CV's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
BRKR vs SMLR Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas SMLR's P/E ratio is 3.92. In terms of profitability, BRKR's ROE is -0.03%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, BRKR is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check SMLR's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
BRKR vs TMCI Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, TMCI has a market cap of 308.1M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while TMCI trades at $4.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas TMCI's P/E ratio is -5.05. In terms of profitability, BRKR's ROE is -0.03%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, BRKR is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check TMCI's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
BRKR vs ANIK Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, ANIK has a market cap of 294.8M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while ANIK trades at $22.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas ANIK's P/E ratio is 44.96. In terms of profitability, BRKR's ROE is -0.03%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, BRKR is less volatile compared to ANIK. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check ANIK's competition here
RxSight, Inc. (NASDAQ: RXST)
BRKR vs RXST Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, RXST has a market cap of 292.3M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while RXST trades at $7.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas RXST's P/E ratio is -7.59. In terms of profitability, BRKR's ROE is -0.03%, compared to RXST's ROE of -0.17%. Regarding short-term risk, BRKR is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check RXST's competition here
Profound Medical Corp. (NASDAQ: PROF)
BRKR vs PROF Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, PROF has a market cap of 251.8M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while PROF trades at $6.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas PROF's P/E ratio is -5.59. In terms of profitability, BRKR's ROE is -0.03%, compared to PROF's ROE of -0.56%. Regarding short-term risk, BRKR is more volatile compared to PROF. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check PROF's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
BRKR vs MGRM Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas MGRM's P/E ratio is -12.00. In terms of profitability, BRKR's ROE is -0.03%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, BRKR is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check MGRM's competition here
Nevro Corp. (NYSE: NVRO)
BRKR vs NVRO Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas NVRO's P/E ratio is -1.91. In terms of profitability, BRKR's ROE is -0.03%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, BRKR is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check NVRO's competition here
Neuronetics, Inc. (NASDAQ: STIM)
BRKR vs STIM Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, STIM has a market cap of 223.4M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while STIM trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas STIM's P/E ratio is -5.94. In terms of profitability, BRKR's ROE is -0.03%, compared to STIM's ROE of -1.51%. Regarding short-term risk, BRKR is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check STIM's competition here
Avita Medical Inc. (NASDAQ: RCEL)
BRKR vs RCEL Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, RCEL has a market cap of 201.7M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while RCEL trades at $8.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas RCEL's P/E ratio is -5.17. In terms of profitability, BRKR's ROE is -0.03%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, BRKR is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check RCEL's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
BRKR vs BSGM Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas BSGM's P/E ratio is -5.81. In terms of profitability, BRKR's ROE is -0.03%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, BRKR is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check BSGM's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
BRKR vs LUCD Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, LUCD has a market cap of 187.8M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while LUCD trades at $0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas LUCD's P/E ratio is -2.66. In terms of profitability, BRKR's ROE is -0.03%, compared to LUCD's ROE of -3.70%. Regarding short-term risk, BRKR is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check LUCD's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
BRKR vs MDGS Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas MDGS's P/E ratio is -0.27. In terms of profitability, BRKR's ROE is -0.03%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, BRKR is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check MDGS's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
BRKR vs FOCL Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, FOCL has a market cap of 178M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while FOCL trades at $4.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas FOCL's P/E ratio is -5.80. In terms of profitability, BRKR's ROE is -0.03%, compared to FOCL's ROE of -1.38%. Regarding short-term risk, BRKR is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check FOCL's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
BRKR vs QIPT Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas QIPT's P/E ratio is -15.87. In terms of profitability, BRKR's ROE is -0.03%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, BRKR is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check QIPT's competition here
Inogen, Inc. (NASDAQ: INGN)
BRKR vs INGN Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, INGN has a market cap of 157.3M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while INGN trades at $5.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas INGN's P/E ratio is -6.38. In terms of profitability, BRKR's ROE is -0.03%, compared to INGN's ROE of -0.13%. Regarding short-term risk, BRKR is more volatile compared to INGN. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check INGN's competition here
Quanterix Corporation (NASDAQ: QTRX)
BRKR vs QTRX Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, QTRX has a market cap of 138M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while QTRX trades at $2.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas QTRX's P/E ratio is -1.83. In terms of profitability, BRKR's ROE is -0.03%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, BRKR is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check QTRX's competition here
iCAD, Inc. (NASDAQ: ICAD)
BRKR vs ICAD Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas ICAD's P/E ratio is -20.37. In terms of profitability, BRKR's ROE is -0.03%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, BRKR is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check ICAD's competition here
Owlet, Inc. (NYSE: OWLT)
BRKR vs OWLT Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, OWLT has a market cap of 105.9M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while OWLT trades at $5.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas OWLT's P/E ratio is -41.79. In terms of profitability, BRKR's ROE is -0.03%, compared to OWLT's ROE of -0.74%. Regarding short-term risk, BRKR is less volatile compared to OWLT. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check OWLT's competition here
Solana Company (NASDAQ: HSDT)
BRKR vs HSDT Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, HSDT has a market cap of 101.6M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while HSDT trades at $1.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas HSDT's P/E ratio is -0.02. In terms of profitability, BRKR's ROE is -0.03%, compared to HSDT's ROE of -1.55%. Regarding short-term risk, BRKR is more volatile compared to HSDT. This indicates higher risk in terms of short-term price fluctuations for BRKR.Check HSDT's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
BRKR vs HJLI Comparison August 2026
Bruker Corporation (NASDAQ: BRKR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKR stands at 9B. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, BRKR is priced at $59.27 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKR currently has a P/E ratio of 29.78, whereas HJLI's P/E ratio is N/A. In terms of profitability, BRKR's ROE is -0.03%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, BRKR is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for BRKR.Check HJLI's competition here